rofecoxib has been researched along with Abdominal Migraine in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibuprofen was included as a reference nonselective NSAID." | 2.72 | Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial. ( Barraclough, E; Dahlof, C; Klipfel, M; Lines, C; Loeys, T; Malbecq, W; Reines, S; Saper, J; So, Y; Tfelt-Hansen, P; Visser, H; Yuen, E, 2006) |
| "Fourteen patients completed baseline and rofecoxib dosing for 2 menstrual cycles." | 2.71 | Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trial. ( Adelman, JU; Mannix, LK; Von Seggern, RL, 2004) |
| "Rofecoxib 25 and 50 mg were superior to placebo in providing pain freedom at 2 hours, 24-hour sustained headache relief, and 24-hour sustained pain freedom; in reducing photophobia, phonophobia, nausea (50 mg only), and functional disability at 2 hours after dose; and in improving some quality-of-life scores over 24 hours." | 2.71 | Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine. ( Brandes, J; Diamond, M; Goldstein, J; Lines, C; Malbecq, W; Reines, S; Silberstein, S; Tepper, S; Venkatraman, S; Visser, WH; Vrijens, F; Winner, P; Yuen, E, 2004) |
| "Rizatriptan is an effective and fast acting drug for the acute treatment of migraine." | 2.71 | Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. ( Bigal, ME; Krymchantowski, AV, 2004) |
| "Both ibuprofen and rofecoxib were superior to placebo in aborting an acute migraine attack, and there was no significant difference in their efficacy in an acute migraine attack." | 2.71 | Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial. ( Jose, M; Kalita, J; Misra, UK, 2004) |
| "Rizatriptan is an effective and fast acting drug for the acute treatment of migraine." | 2.70 | Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. ( Barbosa, JS; Krymchantowski, AV, 2002) |
| "The disability of migraine attacks results in considerable economic and social losses." | 2.43 | Rofecoxib in migraine. ( Bigal, ME; Krymchantowski, AV, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peres, MF | 2 |
| Silberstein, SD | 1 |
| Von Seggern, RL | 1 |
| Mannix, LK | 1 |
| Adelman, JU | 1 |
| Silberstein, S | 1 |
| Tepper, S | 1 |
| Brandes, J | 1 |
| Diamond, M | 1 |
| Goldstein, J | 1 |
| Winner, P | 1 |
| Venkatraman, S | 1 |
| Vrijens, F | 1 |
| Malbecq, W | 2 |
| Lines, C | 2 |
| Visser, WH | 1 |
| Reines, S | 2 |
| Yuen, E | 2 |
| Krymchantowski, AV | 3 |
| Bigal, ME | 2 |
| Misra, UK | 1 |
| Jose, M | 1 |
| Kalita, J | 1 |
| Saper, J | 1 |
| Dahlof, C | 1 |
| So, Y | 1 |
| Tfelt-Hansen, P | 1 |
| Loeys, T | 1 |
| Barraclough, E | 1 |
| Klipfel, M | 1 |
| Visser, H | 1 |
| Zukerman, E | 1 |
| Barbosa, JS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| : An End to the Yom Kippur (and Ramadan) Headache: A Double Blind Placebo Controlled Trial of Prophylactic Rofecoxib in Preventing Ritual Fasting Headache.[NCT00263094] | 220 participants | Interventional | 2004-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for rofecoxib and Abdominal Migraine
| Article | Year |
|---|---|
Rofecoxib in migraine.
Topics: Cyclooxygenase 2 Inhibitors; Expert Testimony; Humans; Lactones; Migraine Disorders; Sulfones | 2005 |
6 trials available for rofecoxib and Abdominal Migraine
| Article | Year |
|---|---|
Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Administration Schedule; Fe | 2004 |
Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.
Topics: Acute Disease; Adult; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Meth | 2004 |
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhi | 2004 |
Rofecoxib versus ibuprofen for acute treatment of migraine: a randomised placebo controlled trial.
Topics: Acute Disease; Adolescent; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; | 2004 |
Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dizziness; Dose-Response Relationship | 2006 |
Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Drug Therapy, | 2002 |
3 other studies available for rofecoxib and Abdominal Migraine
| Article | Year |
|---|---|
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
Topics: Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Lactones; Male; Migraine Disorde | 2002 |
[Selective COX 2 inhibitor rofecoxib. To "defy" the pain].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors | 2003 |
Hemicrania continua responsive to rofecoxib.
Topics: Enzyme Inhibitors; Female; Humans; Lactones; Middle Aged; Migraine Disorders; Sulfones | 2000 |